HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 16 filers reported holding HORIZON PHARMA PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,200,000 | -1.9% | 83,225 | -27.5% | 0.01% | -14.3% |
| Q4 2018 | $2,243,000 | -14.4% | 114,802 | -14.2% | 0.01% | 0.0% |
| Q3 2018 | $2,619,000 | -9.0% | 133,754 | -23.1% | 0.01% | -22.2% |
| Q2 2018 | $2,879,000 | +9.2% | 173,877 | -6.4% | 0.02% | +5.9% |
| Q1 2018 | $2,637,000 | +40.4% | 185,684 | +44.4% | 0.02% | +41.7% |
| Q4 2017 | $1,878,000 | +15.4% | 128,606 | +0.2% | 0.01% | +9.1% |
| Q3 2017 | $1,627,000 | +25.7% | 128,348 | +17.8% | 0.01% | +37.5% |
| Q2 2017 | $1,294,000 | +5.6% | 108,994 | +31.5% | 0.01% | +14.3% |
| Q1 2017 | $1,225,000 | +171.6% | 82,883 | +197.1% | 0.01% | +250.0% |
| Q4 2016 | $451,000 | +132.5% | 27,898 | +161.3% | 0.00% | +100.0% |
| Q3 2016 | $194,000 | +10.2% | 10,677 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $176,000 | – | 10,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,664,219 | $83,717,000 | 10.14% |
| Consonance Capital Management LP | 6,218,903 | $91,915,000 | 9.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,944,988 | $161,767,000 | 6.24% |
| Rhenman & Partners Asset Management AB | 1,751,322 | $25,885,000 | 4.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 9,686,262 | $143,163,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 850,000 | $12,563,000 | 2.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,959,258 | $43,738,000 | 2.40% |
| Proxima Capital Management, LLC | 246,311 | $3,640,000 | 2.22% |
| Beach Point Capital Management LP | 522,898 | $7,728,000 | 2.18% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 165,260 | $2,443,000 | 1.94% |